MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone855-292-8399
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1,000
Next Earnings DateN/A
OptionableNot Optionable
Medmen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions
What is Medmen Enterprises' stock symbol?
Medmen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."
What price target have analysts set for MMNFF?
2 brokerages have issued 1 year price objectives for Medmen Enterprises' shares. Their predictions range from $7.00 to $9.00. On average, they expect Medmen Enterprises' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 287.2% from the stock's current price. View Analyst Price Targets for Medmen Enterprises.
What is the consensus analysts' recommendation for Medmen Enterprises?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medmen Enterprises in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medmen Enterprises.
Has Medmen Enterprises been receiving favorable news coverage?
News coverage about MMNFF stock has been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medmen Enterprises earned a media sentiment score of 1.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Medmen Enterprises.
Who are some of Medmen Enterprises' key competitors?
Some companies that are related to Medmen Enterprises include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH) and Cosmos (COSM).
What other stocks do shareholders of Medmen Enterprises own?
Who are Medmen Enterprises' key executives?
Medmen Enterprises' management team includes the folowing people:
- Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)
- Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)
- Mr. Michael W. Kramer, Chief Financial Officer (Age 55)
- Mr. James Miller, VP of Accounting (Age 59)
- Mr. Ryan Lissack, Chief Technology Officer
How do I buy shares of Medmen Enterprises?
Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medmen Enterprises' stock price today?
One share of MMNFF stock can currently be purchased for approximately $2.0661.
What is Medmen Enterprises' official website?
How can I contact Medmen Enterprises?
The company can be reached via phone at 855-292-8399.
MarketBeat Community Rating for Medmen Enterprises (OTCMKTS MMNFF)
MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote "Outperform" if you believe MMNFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMNFF will underperform the S&P 500 over the long term. You may vote once every thirty days.
